SAN

99.21

-3.74%↓

EI

265.7

-0.97%↓

ARGX

524.2

-3.85%↓

FRE

38.84

-2.26%↓

PHIA

22.93

-3.45%↓

SAN

99.21

-3.74%↓

EI

265.7

-0.97%↓

ARGX

524.2

-3.85%↓

FRE

38.84

-2.26%↓

PHIA

22.93

-3.45%↓

SAN

99.21

-3.74%↓

EI

265.7

-0.97%↓

ARGX

524.2

-3.85%↓

FRE

38.84

-2.26%↓

PHIA

22.93

-3.45%↓

SAN

99.21

-3.74%↓

EI

265.7

-0.97%↓

ARGX

524.2

-3.85%↓

FRE

38.84

-2.26%↓

PHIA

22.93

-3.45%↓

SAN

99.21

-3.74%↓

EI

265.7

-0.97%↓

ARGX

524.2

-3.85%↓

FRE

38.84

-2.26%↓

PHIA

22.93

-3.45%↓

Search

Siemens Healthineers AG

Avatud

SektorTervishoid

49.46 -1.71

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

49.22

Max

50.3

Põhinäitajad

By Trading Economics

Sissetulek

-138M

478M

Müük

-848M

5.5B

P/E

Sektori keskmine

28.028

63.778

Aktsiakasum

0.51

Dividenditootlus

1.87

Kasumimarginaal

8.719

Töötajad

73,100

EBITDA

-223M

1B

Soovitused

By TipRanks

Soovitused

Osta

12 kuu keskmine prognoos

+26.11% upside

Dividendid

By Dow Jones

Dividenditootlus

Sektori keskmine

1.87%

2.39%

Järgmine tulemuste avaldamine

7. mai 2025

Turustatistika

By TradingEconomics

Turukapital

-6B

56B

Eelmine avamishind

51.17

Eelmine sulgemishind

49.46

Uudiste sentiment

By Acuity

39%

61%

134 / 386 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

Siemens Healthineers AG Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

20. veebr 2025, 07:32 UTC

Omandamised, ülevõtmised, äriostud

Siemens Raises $1.5 Billion From Siemens Healthineers Stake Sale

6. veebr 2025, 06:20 UTC

Tulu

Siemens Healthineers Profit, Sales Beat Market Views

27. märts 2025, 11:21 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

ProSiebenSat.1's Stock Seen With Speculative Appeal Amid MFE's Takeover Bid -- Market Talk

27. märts 2025, 11:05 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

MFE's ProSiebenSat.1 Bid Seen as Attempt to Avoid Pricier Mandatory Takeover -- Market Talk

27. märts 2025, 10:23 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

MFE's Takeover Bid for ProSiebenSat.1 is Unfavorable to Minority Shareholders -- Market Talk

20. veebr 2025, 12:53 UTC

Market Talk
Omandamised, ülevõtmised, äriostud

Siemens Stake Cut Boosts Siemens Healthineers Stock Liquidity -- Market Talk

6. veebr 2025, 15:54 UTC

Market Talk
Tulu

Siemens Healthineers 1Q Is Step in Right Direction -- Market Talk

6. veebr 2025, 13:39 UTC

Market Talk
Tulu

Siemens Healthineers Could Exceed Outlook After 1Q Beat, Better-Than Expected China Sales -- Market Talk

6. veebr 2025, 06:00 UTC

Tulu

Siemens Healthineers Backs 2025 View

6. veebr 2025, 06:00 UTC

Tulu

Analysts Saw Siemens Healthineers 1Q Net Profit EUR439M

6. veebr 2025, 06:00 UTC

Tulu

Siemens Healthineers Had Seen 2025 Adj. Basic Earnings Per Share of EUR2.35 to EUR2.50

6. veebr 2025, 06:00 UTC

Tulu

Siemens Healthineers Had Seen 2025 Revenue Growth of 5% to 6%

6. veebr 2025, 06:00 UTC

Tulu

Siemens Healthineers 1Q Net Pft EUR474M

6. veebr 2025, 06:00 UTC

Tulu

Siemens Healthineers 1Q Rev EUR5.48B

6. veebr 2025, 06:00 UTC

Tulu

Siemens Healthineers 1Q EBIT EUR698M

6. veebr 2025, 06:00 UTC

Tulu

Analysts Saw Siemens Healthineers 1Q Revenue at EUR5.37B

6. veebr 2025, 06:00 UTC

Tulu

Siemens Healthineers 1Q Adj EBIT EUR822M

6. veebr 2025, 06:00 UTC

Tulu

Siemens Healthineers 1Q Adj Basic Earnings Per Share EUR0.51

6. veebr 2025, 06:00 UTC

Tulu

Analysts Saw Siemens Healthineers 1Q EBIT EUR802M

6. nov 2024, 11:16 UTC

Tulu

Siemens Healthineers Shares Jump After It Met Targets Despite Weak China Demand -- Update

6. nov 2024, 06:22 UTC

Tulu

Siemens Healthineers Net Profit, Revenue Miss Views

6. nov 2024, 06:10 UTC

Tulu

Correct: Siemens Healthineers 4Q Adjusted EBIT Margin 17.7%

6. nov 2024, 06:00 UTC

Tulu

Analysts Saw Siemens Healthineers 4Q Revenue at EUR6.36B

6. nov 2024, 06:00 UTC

Tulu

Analysts Saw Siemens Healthineers 4Q Comparable Revenue Growth at 5.6%

6. nov 2024, 06:00 UTC

Tulu

Siemens Healthineers 4Q Net Pft EUR616M

6. nov 2024, 06:00 UTC

Tulu

Siemens Healthineers 4Q Adj EPS EUR0.67

6. nov 2024, 06:00 UTC

Tulu

Siemens Healthineers Says It Achieved FY 2024 Targets With Strong 4Q

6. nov 2024, 06:00 UTC

Tulu

Siemens Healthineers 4Q Adjusted EBIT Margin 17.1%

6. nov 2024, 06:00 UTC

Tulu

Siemens Healthineers 4Q EBIT EUR948M

6. nov 2024, 06:00 UTC

Tulu

Siemens Healthineers Keeps Dividend at EUR0.95

Võrdlus sarnastega

Hinnamuutus

Siemens Healthineers AG Prognoos

Hinnasiht

By TipRanks

26.11% tõus

12 kuu keskmine prognoos

Keskmine 62.565 EUR  26.11%

Kõrge 69.1 EUR

Madal 53 EUR

Põhineb 14 Wall Streeti analüütiku instrumendi Siemens Healthineers AG 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

14 ratings

10

Osta

4

Hoia

0

Müü

Tehniline skoor

By Trading Central

N/A / 50.66Toetus ja vastupanu

Lühikene perspektiiv

Very Strong Bearish Evidence

Keskpikk perspektiiv

Weak Bearish Evidence

Pikk perspektiiv

Very Strong Bearish Evidence

Sentiment

By Acuity

134 / 386 Pingereas Tervishoid

Uudiste sentiment

Languse märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Siemens Healthineers AG

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company was incorporated in 2017 and is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.